Intra-Cellular Therapies (ITCI) Applies for FDA Approval of CAPLYTA for the Treatment of Bipolar Depression - StreetInsider.com

Submitted by Anonymous (not verified) on Mon, 02/22/2021 - 13:37

Intra-Cellular Therapies (ITCI) Applies for FDA Approval of CAPLYTA for the Treatment of Bipolar Depression  StreetInsider.com